Brinzolamide Powder
Product Images NDC 62207-011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 62207-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4987e688 4c55 2d5c E054 00144ff8d46c

Label for Brinzolamide USP powder bulk ingredient, 25 kg container, by Granules India Limited. The label includes batch, manufacturing, and expiry date fields, gross and net weights, storage instructions specifying 20°C-25°C (68°F-77°F), and caution for manufacturing and repacking. Manufactured in India by Granules India Limited located in Andhra Pradesh.*

FDA Label Image

62207-011-01 (62207 011 01)

Label for Brinzolamide USP bulk ingredient powder by Granules India Limited. This packaging label includes batch, manufacturing, and expiration details fields, along with storage instructions specifying tight containers and temperature range 20-25°C, with excursions allowed between 15-30°C. The label also lists the manufacturing license number and the NDC 62207-011-01. Manufacturer details and country of origin (India) are shown with the Granules logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.